Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Brian K. Kaspar,1
Jerònia Lladó,2*
Nushin Sherkat,1
Jeffrey D. Rothstein,2
Fred H. Gage1
Abstract:
Amyotrophic lateral sclerosis (ALS) is a progressive, lethalneuromuscular disease that is associated with the degenerationof spinal and brainstem motor neurons, leading to atrophy oflimb, axial, and respiratory muscles. The cause of ALS is unknown,and there is no effective therapy. Neurotrophic factors arecandidates for therapeutic evaluation in ALS. Although chronicdelivery of molecules to the central nervous system has provendifficult, we recently discovered that adeno-associated viruscan be retrogradely transported efficiently from muscle to motorneurons of the spinal cord. We report that insulin-like growthfactor 1 prolongs life and delays disease progression, evenwhen delivered at the time of overt disease symptoms.
1 Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA. 2 Departments of Neurology and Neuroscience, Johns Hopkins University, 600 North Wolfe Street, Meyer 6-109, Baltimore, MD 21287, USA.
Subventricular Zone-Derived Neural Stem Cell Grafts Protect Against Hippocampal Degeneration and Restore Cognitive Function in the Mouse Following Intrahippocampal Kainic Acid Administration.
P. Miltiadous, G. Kouroupi, A. Stamatakis, P. N. Koutsoudaki, R. Matsas, and F. Stylianopoulou (2013)
Stem Cells Trans Med
2, 185-198
|Abstract »|Full Text »|PDF »
Myelin Loss Does Not Lead to Axonal Degeneration in a Long-Lived Model of Chronic Demyelination.
C. M. Smith, E. Cooksey, and I. D. Duncan (2013)
J. Neurosci.
33, 2718-2727
|Abstract »|Full Text »|PDF »
Multimodal Actions of Neural Stem Cells in a Mouse Model of ALS: A Meta-Analysis.
Y. D. Teng, S. C. Benn, S. N. Kalkanis, J. M. Shefner, R. C. Onario, B. Cheng, M. B. Lachyankar, M. Marconi, J. Li, D. Yu, et al. (2012)
Science Translational Medicine
4, 165ra164
|Abstract »|Full Text »|PDF »
Upregulation of the E3 ligase NEDD4-1 by Oxidative Stress Degrades IGF-1 Receptor Protein in Neurodegeneration.
Y.-D. Kwak, B. Wang, J. J. Li, R. Wang, Q. Deng, S. Diao, Y. Chen, R. Xu, E. Masliah, H. Xu, et al. (2012)
J. Neurosci.
32, 10971-10981
|Abstract »|Full Text »|PDF »
Impairments to the GH-IGF-I Axis in hSOD1G93A Mice Give Insight into Possible Mechanisms of GH Dysregulation in Patients with Amyotrophic Lateral Sclerosis.
F. J. Steyn, S. T. Ngo, J. D. Lee, J. W. Leong, A. J. Buckley, J. D. Veldhuis, P. A. McCombe, C. Chen, and M. C. Bellingham (2012)
Endocrinology
153, 3735-3746
|Abstract »|Full Text »|PDF »
Human Axonal Survival of Motor Neuron (a-SMN) Protein Stimulates Axon Growth, Cell Motility, C-C Motif Ligand 2 (CCL2), and Insulin-like Growth Factor-1 (IGF1) Production.
D. Locatelli, M. Terao, M. Fratelli, A. Zanetti, M. Kurosaki, M. Lupi, M. M. Barzago, A. Uggetti, S. Capra, P. D'Errico, et al. (2012)
J. Biol. Chem.
287, 25782-25794
|Abstract »|Full Text »|PDF »
The in vivo contribution of motor neuron TrkB receptors to mutant SOD1 motor neuron disease.
J. Zhai, W. Zhou, J. Li, C. R. Hayworth, L. Zhang, H. Misawa, R. Klein, S. S. Scherer, R. J. Balice-Gordon, and R. G. Kalb (2011)
Hum. Mol. Genet.
20, 4116-4131
|Abstract »|Full Text »|PDF »
Increased IGF-1 in muscle modulates the phenotype of severe SMA mice.
M. Bosch-Marce, C. D. Wee, T. L. Martinez, C. E. Lipkes, D. W. Choe, L. Kong, J. P. Van Meerbeke, A. Musaro, and C. J. Sumner (2011)
Hum. Mol. Genet.
20, 1844-1853
|Abstract »|Full Text »|PDF »
Genetic therapy for the nervous system.
W. J. Bowers, X. O. Breakefield, and M. Sena-Esteves (2011)
Hum. Mol. Genet.
20, R28-R41
|Abstract »|Full Text »|PDF »
Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.
E. Hedlund, M. Karlsson, T. Osborn, W. Ludwig, and O. Isacson (2010)
Brain
133, 2313-2330
|Abstract »|Full Text »|PDF »
Collapsin Response Mediator Protein 4a (CRMP4a) Is Upregulated in Motoneurons of Mutant SOD1 Mice and Can Trigger Motoneuron Axonal Degeneration and Cell Death.
L. Duplan, N. Bernard, W. Casseron, K. Dudley, E. Thouvenot, J. Honnorat, V. Rogemond, B. De Bovis, P. Aebischer, P. Marin, et al. (2010)
J. Neurosci.
30, 785-796
|Abstract »|Full Text »|PDF »
Role and Therapeutic Potential of VEGF in the Nervous System.
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet (2009)
Physiol Rev
89, 607-648
|Abstract »|Full Text »|PDF »
Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.
C. S. Lobsiger, S. Boillee, M. McAlonis-Downes, A. M. Khan, M. L. Feltri, K. Yamanaka, and D. W. Cleveland (2009)
PNAS
106, 4465-4470
|Abstract »|Full Text »|PDF »
Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.
F. F. Rose Jr, V. B. Mattis, H. Rindt, and C. L. Lorson (2009)
Hum. Mol. Genet.
18, 997-1005
|Abstract »|Full Text »|PDF »
Efficient gene therapy-based method for the delivery of therapeutics to primate cortex.
A. P. Kells, P. Hadaczek, D. Yin, J. Bringas, V. Varenika, J. Forsayeth, and K. S. Bankiewicz (2009)
PNAS
106, 2407-2411
|Abstract »|Full Text »|PDF »
Insulin-Like Growth Factors in the Peripheral Nervous System.
K. A. Sullivan, B. Kim, and E. L. Feldman (2008)
Endocrinology
149, 5963-5971
|Abstract »|Full Text »|PDF »
Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis.
C. Pitzer, C. Kruger, C. Plaas, F. Kirsch, T. Dittgen, R. Muller, R. Laage, S. Kastner, S. Suess, R. Spoelgen, et al. (2008)
Brain
131, 3335-3347
|Abstract »|Full Text »|PDF »
T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.
I. M. Chiu, A. Chen, Y. Zheng, B. Kosaras, S. A. Tsiftsoglou, T. K. Vartanian, R. H. Brown Jr, and M. C. Carroll (2008)
PNAS
105, 17913-17918
|Abstract »|Full Text »|PDF »
IGFBP-5 regulates muscle cell differentiation by binding to IGF-II and switching on the IGF-II auto-regulation loop.
Mesenchymal stromal cells genetically engineered to overexpress IGF-I enhance cell-based gene therapy of renal failure-induced anemia.
T. Kucic, I. B. Copland, J. Cuerquis, D. L. Coutu, L. E. Chalifour, R. F. Gagnon, and J. Galipeau (2008)
Am J Physiol Renal Physiol
295, F488-F496
|Abstract »|Full Text »|PDF »
Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice.
K. Yamanaka, S. Boillee, E. A. Roberts, M. L. Garcia, M. McAlonis-Downes, O. R. Mikse, D. W. Cleveland, and L. S. B. Goldstein (2008)
PNAS
105, 7594-7599
|Abstract »|Full Text »|PDF »
Adeno-Associated Virus Transfer of a Gene Encoding SNAP-25 Resistant to Botulinum Toxin A Attenuates Neuromuscular Paralysis Associated with Botulism.
A. Raghunath, F. Perez-Branguli, L. Smith, and J. O. Dolly (2008)
J. Neurosci.
28, 3683-3688
|Abstract »|Full Text »|PDF »
The Neurotrophic Effects of Glial Cell Line-Derived Neurotrophic Factor on Spinal Motoneurons Are Restricted to Fusimotor Subtypes.
T. W. Gould, S. Yonemura, R. W. Oppenheim, S. Ohmori, and H. Enomoto (2008)
J. Neurosci.
28, 2131-2146
|Abstract »|Full Text »|PDF »
Neurodegeneration and cell replacement.
B. K Ormerod, T. D Palmer, and M. A Caldwell (2008)
Phil Trans R Soc B
363, 153-170
|Abstract »|Full Text »|PDF »
Exogenous Delivery of Heat Shock Protein 70 Increases Lifespan in a Mouse Model of Amyotrophic Lateral Sclerosis.
D. J. Gifondorwa, M. B. Robinson, C. D. Hayes, A. R. Taylor, D. M. Prevette, R. W. Oppenheim, J. Caress, and C. E. Milligan (2007)
J. Neurosci.
27, 13173-13180
|Abstract »|Full Text »|PDF »
A Single Injection of an Adeno-Associated Virus Vector into Nuclei with Divergent Connections Results in Widespread Vector Distribution in the Brain and Global Correction of a Neurogenetic Disease.
Interaction between Familial Amyotrophic Lateral Sclerosis (ALS)-linked SOD1 Mutants and the Dynein Complex.
F. Zhang, A.-L. Strom, K. Fukada, S. Lee, L. J. Hayward, and H. Zhu (2007)
J. Biol. Chem.
282, 16691-16699
|Abstract »|Full Text »|PDF »
Concurrent Administration of Neu2000 and Lithium Produces Marked Improvement of Motor Neuron Survival, Motor Function, and Mortality in a Mouse Model of Amyotrophic Lateral Sclerosis.
J. H. Shin, S. I. Cho, H. R. Lim, J. K. Lee, Y. A. Lee, J. S. Noh, I. S. Joo, K.-W. Kim, and B. J. Gwag (2007)
Mol. Pharmacol.
71, 965-975
|Abstract »|Full Text »|PDF »
Cortical area size dictates performance at modality-specific behaviors.
A. Leingartner, S. Thuret, T. T. Kroll, S.-J. Chou, J. L. Leasure, F. H. Gage, and D. D. M. O'Leary (2007)
PNAS
104, 4153-4158
|Abstract »|Full Text »|PDF »
Respiratory impairment in a mouse model of amyotrophic lateral sclerosis.
C. G. Tankersley, C. Haenggeli, and J. D. Rothstein (2007)
J Appl Physiol
102, 926-932
|Abstract »|Full Text »|PDF »
Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis.
T. M. Miller, S. H. Kim, K. Yamanaka, M. Hester, P. Umapathi, H. Arnson, L. Rizo, J. R. Mendell, F. H. Gage, D. W. Cleveland, et al. (2006)
PNAS
103, 19546-19551
|Abstract »|Full Text »|PDF »
Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.
D. R. Beers, J. S. Henkel, Q. Xiao, W. Zhao, J. Wang, A. A. Yen, L. Siklos, S. R. McKercher, and S. H. Appel (2006)
PNAS
103, 16021-16026
|Abstract »|Full Text »|PDF »
The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice.
D.-C. Wu, D. B. Re, M. Nagai, H. Ischiropoulos, and S. Przedborski (2006)
PNAS
103, 12132-12137
|Abstract »|Full Text »|PDF »
Neuroprotective agents for clinical trials in ALS: A systematic assessment..
B. J. Traynor, L. Bruijn, R. Conwit, F. Beal, G. O'Neill, S. C. Fagan, and M. E. Cudkowicz (2006)
Neurology
67, 20-27
|Abstract »|Full Text »|PDF »
Informatics-assisted Protein Profiling in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
T. J. Lukas, W. W. Luo, H. Mao, N. Cole, and T. Siddique (2006)
Mol. Cell. Proteomics
5, 1233-1244
|Abstract »|Full Text »|PDF »
Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities.
R. S. Devon, P. C. Orban, K. Gerrow, M. A. Barbieri, C. Schwab, L. P. Cao, J. R. Helm, N. Bissada, R. Cruz-Aguado, T.-L. Davidson, et al. (2006)
PNAS
103, 9595-9600
|Abstract »|Full Text »|PDF »
Risks, benefits, and consent in the age of gene therapy.
J. R. Mendell and K. R. Clark (2006)
Neurology
66, 964-965
|Full Text »|PDF »
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway.
A. Yamamoto, M. L. Cremona, and J. E. Rothman (2006)
J. Cell Biol.
172, 719-731
|Abstract »|Full Text »|PDF »
Intracranial Delivery of CLN2 Reduces Brain Pathology in a Mouse Model of Classical Late Infantile Neuronal Ceroid Lipofuscinosis.
M. A. Passini, J. C. Dodge, J. Bu, W. Yang, Q. Zhao, D. Sondhi, N. R. Hackett, S. M. Kaminsky, Q. Mao, L. S. Shihabuddin, et al. (2006)
J. Neurosci.
26, 1334-1342
|Abstract »|Full Text »|PDF »
The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain.
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther (2005)
Endocr. Rev.
26, 916-943
|Abstract »|Full Text »|PDF »
Tau Is Hyperphosphorylated in the Insulin-Like Growth Factor-I Null Brain.
C. M. Cheng, V. Tseng, J. Wang, D. Wang, L. Matyakhina, and C. A. Bondy (2005)
Endocrinology
146, 5086-5091
|Abstract »|Full Text »|PDF »
Clinical Trials in Amyotrophic Lateral Sclerosis: The Tenuous Past and the Promising Future.
R. B. Choudry and M. E. Cudkowicz (2005)
J. Clin. Pharmacol.
45, 1334-1344
|Abstract »|Full Text »|PDF »
Intraneuronal {beta}-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response.
J. Magrane, K. M. Rosen, R. C. Smith, K. Walsh, G. K. Gouras, and H. W. Querfurth (2005)
J. Neurosci.
25, 10960-10969
|Abstract »|Full Text »|PDF »
No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model.
F. E. Perrin, G. Boisset, M. Docquier, O. Schaad, P. Descombes, and A. C. Kato (2005)
Hum. Mol. Genet.
14, 3309-3320
|Abstract »|Full Text »|PDF »
Amelioration of laminin-{alpha}2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin.
C. Qiao, J. Li, T. Zhu, R. Draviam, S. Watkins, X. Ye, C. Chen, J. Li, and X. Xiao (2005)
PNAS
102, 11999-12004
|Abstract »|Full Text »|PDF »
Molecular Endocrinology and Physiology of the Aging Central Nervous System.
A Rac1/Phosphatidylinositol 3-Kinase/Akt3 Anti-apoptotic Pathway, Triggered by AlsinLF, the Product of the ALS2 Gene, Antagonizes Cu/Zn-superoxide Dismutase (SOD1) Mutant-induced Motoneuronal Cell Death.
K. Kanekura, Y. Hashimoto, Y. Kita, J. Sasabe, S. Aiso, I. Nishimoto, and M. Matsuoka (2005)
J. Biol. Chem.
280, 4532-4543
|Abstract »|Full Text »|PDF »
Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model.
G. Dobrowolny, C. Giacinti, L. Pelosi, C. Nicoletti, N. Winn, L. Barberi, M. Molinaro, N. Rosenthal, and A. Musaro (2005)
J. Cell Biol.
168, 193-199
|Abstract »|Full Text »|PDF »
Gene transfer for neurologic disease: Agencies, policies, and process.